Oral presenters are required to prepare for your oral presentation according to the guidelines below.
Presentation Specifications
Presentation Language: English
Length of presentation:
Oral Presenter will be allocated 8 minutes for presentation (including any videos) and 4 minutes for questions and answers each. Total of 12 minutes.
Shortlisted Oral Presenters and Young Investigator Awardees will be allocated 10 minutes for presentation (including any videos) and 5 minutes for questions and answers each. Total of 15 minutes.
Presentation Format:
Important note for Macintoch users:
In order to use MAC presentations on a PC compatible computer please note that you need to prepare it according to the instructions below, before bringing it to the Speakers’ Ready Room:
Alternatively, you may use your own Macintosh laptop computer. In such a case please provide it with a VGA adaptor for external signal, advise the operators in the Speaker Preparation room about it as soon as you arrive and later test it in the session hall where your lecture is taking place during the coffee or lunch break prior to your session, at least 30 minutes before the start of the session.
Speaker Preparation Room
Oral presenters are requested to upload your PowerPoint slide presentations at the Speakers Preparation room at least 2 hours prior to your session.
There will be a technician available to assist you during the following hours:
At the Session Room
If you have any questions about the information about, email aspire@theconferencecompany.com.
FEATURED Oral Presentations
Young Investigator Awardee / Shortlisted Oral Presentations
Abstract Number | Abstract Title | Abstract Theme | Presenting Author | Presentation Schedule |
150 | DO WOMEN WITH A HISTORY OF RECURRENT MISCARRIAGE HAVE A HIGHER RISK OF OBSTETRIC AND PERINATAL COMPLICATIONS IN A SUBSEQUENT PREGNANCY? A COHORT STUDY. | ART Clinical | Dr Xiaoyan Chen | Free Communication 38 |
225 | MIR-135B EXPRESSION CORRELATED WITH ANEUPLOIDY IN TROPHECTODERM FROM IVF PATIENTS: AN APPROACH TO NIR-INVASIVE SCREENING FOR EMBRYO QUALITY ASSESSMENT | ART, Basic Research | Ms Kresna Mutia | Free Communication 38 |
48 | BLASTOCYST VERSUS DAY-3 EMBRYO TRANSFERS AFTER IN VITRO MATURATION WITH PRE-MATURATION STEP (CAPA-IVM) IN PCOS PATIENTS | ART, Laboratory | Mr Huy Pham | Free Communication 22 |
38 | MATERNAL AGE AFFECTS MORULA COMPACTION AND CELL POLARITY OF HUMAN EMBRYOS | Embryology | Mr Kenji Ezoe | Free Communication 22 |
315 | DETERMINATION OF CLINICAL PREGNANCY AND LIVE BIRTH RATES IN AUTOLOGOUS CYCLES FOR WOMEN BETWEEN 40 AND 46 YEARS OLD | ART Clinical | Dr Lucy Owens | Free Communication 39 |
77 | A MICRO 3D PRINTED DEVICE FOR INTRACYTOPLASMIC SPERM INJECTION REMOVES THE REQUIREMENT FOR A HOLDING PIPETTE AND REDUCES COMPLEXITY OF THE PROCEDURE | ART, Basic Research | Mrs Megan Inge | Free Communication 39 |
230 | THE EFFECTIVENESS OF SPERMATID INJECTION (ROSI, ELSI) VERSUS SPERMATOZOA INJECTION (ICSI) IN INFERTILITY TREATMENT FOR MEN WITH NON-OBSTRUCTIVE AZOOSPERMIA (NOA) | Male Fertility | Mr Van Tang | Free Communication 39 |
56 | PREGNANCY AND LIVE BIRTH RATES IN MINIMAL STIMULATION IVF CYCLES FROM RESCUE IN-VITRO MATURATION OF OOCYTES | ART, Laboratory | Dr Rudie Frederick Mendiola | Free Communication 16 |
169 | THE USE OF PIEZO-ICSI INCREASES FERTILISATION AND LOWERS DEGENERATION RATES WHEN COMPARED TO CONVENTIONAL ICSI: IN A SINGAPORE SETTING. | ART, Laboratory | Mr Wei Hou Lim | Free Communication 16 |
81 | RESULT OF NON-INVASIVE PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY IN DIFFERENT CULTURE MEDIUM CONDITION | Preimplantation Screening and Diagnosis | Mrs Pritta Ameilia Iffanolida | Free Communication 16 |
161 | VALIDATION AND CONCORDANCE OF NON-INVASIVE PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY(NIPGT-A) USING CELL FREE DNA FROM SPENT CULTURE MEDIA(SCM) WITH GOLD STANDARD TROPHECTODERM BIOSPY | Preimplantation Screening and Diagnosis | Prof Neeta Singh | Free Communication 16 |
165 | APPLICATION OF A HIGHLY RELIABLE PROTOCOL OF NON-INVASIVE PREIMPLANTATION GENETIC TESTING FOR IVF CYCLES AND ITS CLINICAL OUTCOME | Preimplantation Screening and Diagnosis | Dr Yen-An Tang | Free Communication 16 |
389 | FERTILITY PRESERVATION DURING CHEMOTHERAPY TREATMENT BY NAD+ REPLETION IN MICE | Fertility Preservation | Prof Robert Gilchrist | Free Communication 39 |
337 | SIX CHARACTERS OF SEMINIFEROUS TUBULES APPEARANCES DURING MICRO-TESE RELATED WITH DIFFERENT SPERM RETRIEVAL RATE | Male Fertility | Dr Jing Zhang | Free Communication 39 |